A Phase 2 Efficacy and Safety, Open-label, Multicenter S

  • Gada, Purvi (PI)

Project: Research project

Description

A Phase 2 Efficacy and Safety, Open-label, Multicenter Study of Imprime PGG Injection in Combination with Cetuximab (Erbitux) in Subjects with Stage IV KRAS-Mutated Colorectal Cancer
StatusFinished
Effective start/end date1/1/083/30/11

Funding

  • BIOTHERA

Fingerprint

Prostaglandins G
Multicenter Studies
Colorectal Neoplasms
Safety
Injections
Cetuximab